HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 242 filers reported holding HORIZON PHARMA PLC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $10,132,000 | +26.3% | 383,351 | -6.6% | 0.01% | +16.7% |
Q4 2018 | $8,024,000 | -4.1% | 410,631 | -3.9% | 0.01% | +20.0% |
Q3 2018 | $8,368,000 | +26.0% | 427,371 | +6.6% | 0.01% | 0.0% |
Q2 2018 | $6,640,000 | +18.7% | 400,954 | +1.7% | 0.01% | +25.0% |
Q1 2018 | $5,596,000 | +2.6% | 394,070 | +5.5% | 0.00% | 0.0% |
Q4 2017 | $5,454,000 | +72.3% | 373,581 | +49.6% | 0.00% | +100.0% |
Q3 2017 | $3,166,000 | +0.3% | 249,702 | -6.1% | 0.00% | 0.0% |
Q2 2017 | $3,158,000 | -94.7% | 266,020 | -93.5% | 0.00% | -95.8% |
Q1 2017 | $60,081,000 | +4.9% | 4,064,995 | +14.8% | 0.05% | 0.0% |
Q4 2016 | $57,269,000 | +1147.1% | 3,539,509 | +1297.6% | 0.05% | +1100.0% |
Q3 2016 | $4,592,000 | +6.3% | 253,260 | -3.4% | 0.00% | 0.0% |
Q2 2016 | $4,318,000 | +92.4% | 262,160 | +203.4% | 0.00% | +100.0% |
Q1 2015 | $2,244,000 | +101.6% | 86,400 | 0.0% | 0.00% | +100.0% |
Q4 2014 | $1,113,000 | +5.0% | 86,400 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $1,060,000 | – | 86,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |